Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$44.75
At close: May 20, 7:26 PM EDT
$44.17
-0.58-1.29%
After Hours: 7:26 PM EDT
Comments
Loading...
Marex Group Analyst Ratings and Price Targets | NASDAQ:MRX | Benzinga
Marex Group PLC has a consensus price target of $38 based on the ratings of 8 analysts. The high is $54 issued by Keefe, Bruyette & Woods on May 16, 2025. The low is $24 issued by Jefferies on May 20, 2024. The 3 most-recent analyst ratings were released by Goldman Sachs, Keefe, Bruyette & Woods, and Barclays on May 16, 2025, May 16, 2025, and April 7, 2025, respectively. With an average price target of $48.67 between Goldman Sachs, Keefe, Bruyette & Woods, and Barclays, there's an implied 10.17% upside for Marex Group PLC from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
Keefe, Bruyette & Woods
Barclays
Piper Sandler
HSBC
1calculated from analyst ratings
Analyst Ratings for Marex Group
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2025 | Buy Now | 8.66% | Goldman Sachs | Alexander Blostein73% | $42 → $48 | Maintains | Buy | Get Alert |
| 05/16/2025 | Buy Now | 22.25% | Keefe, Bruyette & Woods | Kyle Voigt68% | $45 → $54 | Maintains | Outperform | Get Alert |
| 04/07/2025 | Buy Now | -0.39% | Barclays | Benjamin Budish81% | $43 → $44 | Maintains | Overweight | Get Alert |
| 04/03/2025 | Buy Now | -0.39% | Goldman Sachs | Alexander Blostein73% | $40 → $44 | Maintains | Buy | Get Alert |
| 03/07/2025 | Buy Now | -9.45% | Goldman Sachs | Alexander Blostein73% | $36 → $40 | Maintains | Buy | Get Alert |
| 03/07/2025 | Buy Now | -2.65% | Barclays | Benjamin Budish81% | $39 → $43 | Maintains | Overweight | Get Alert |
| 01/13/2025 | Buy Now | -11.71% | Barclays | Benjamin Budish81% | $35 → $39 | Maintains | Overweight | Get Alert |
| 01/07/2025 | Buy Now | -9.45% | Piper Sandler | Patrick Moley84% | $32 → $40 | Maintains | Overweight | Get Alert |
| 12/20/2024 | Buy Now | -18.5% | Keefe, Bruyette & Woods | Kyle Voigt68% | $33 → $36 | Maintains | Outperform | Get Alert |
| 12/09/2024 | Buy Now | -20.77% | Barclays | Benjamin Budish81% | $32 → $35 | Maintains | Overweight | Get Alert |
| 11/21/2024 | Buy Now | -25.29% | HSBC | Carlos Gomez-Lopez70% | → $33 | Initiates | → Buy | Get Alert |
| 11/08/2024 | Buy Now | -27.56% | Barclays | Benjamin Budish81% | $30 → $32 | Maintains | Overweight | Get Alert |
| 11/08/2024 | Buy Now | -25.29% | Keefe, Bruyette & Woods | Kyle Voigt68% | $30 → $33 | Maintains | Outperform | Get Alert |
| 11/08/2024 | Buy Now | -27.56% | Piper Sandler | Patrick Moley84% | $30 → $32 | Maintains | Overweight | Get Alert |
| 11/06/2024 | Buy Now | -23.03% | Citigroup | Chris Allen77% | → $34 | Reinstates | Buy → Buy | Get Alert |
| 10/07/2024 | Buy Now | -32.08% | Barclays | Benjamin Budish81% | $28 → $30 | Maintains | Overweight | Get Alert |
| 08/15/2024 | Buy Now | -32.08% | Piper Sandler | Patrick Moley84% | $27 → $30 | Maintains | Overweight | Get Alert |
| 08/15/2024 | Buy Now | -36.61% | Barclays | Benjamin Budish81% | $25 → $28 | Maintains | Overweight | Get Alert |
| 08/14/2024 | Buy Now | -38.88% | Piper Sandler | Patrick Moley84% | $27 → $27 | Reiterates | Overweight → Overweight | Get Alert |
| 05/20/2024 | Buy Now | -38.88% | UBS | Alex Kramm73% | → $27 | Initiates | → Buy | Get Alert |
| 05/20/2024 | Buy Now | -45.67% | Citigroup | Chris Allen77% | → $24 | Initiates | → Buy | Get Alert |
| 05/20/2024 | Buy Now | -43.4% | Barclays | Benjamin Budish81% | → $25 | Initiates | → Overweight | Get Alert |
| 05/20/2024 | Buy Now | -45.67% | Jefferies | Daniel Fannon70% | → $24 | Initiates | → Buy | Get Alert |
| 05/20/2024 | Buy Now | -45.67% | Keefe, Bruyette & Woods | Kyle Voigt68% | → $24 | Initiates | → Outperform | Get Alert |
| 05/20/2024 | Buy Now | -38.88% | Piper Sandler | Patrick Moley84% | → $27 | Initiates | → Overweight | Get Alert |
| 05/20/2024 | Buy Now | -25.29% | Goldman Sachs | Alexander Blostein73% | → $33 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Marex Group (MRX) stock?
The latest price target for Marex Group (NASDAQ:MRX) was reported by Goldman Sachs on May 16, 2025. The analyst firm set a price target for $48.00 expecting MRX to rise to within 12 months (a possible 8.66% upside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Marex Group (MRX)?
The latest analyst rating for Marex Group (NASDAQ:MRX) was provided by Goldman Sachs, and Marex Group maintained their buy rating.
When was the last upgrade for Marex Group (MRX)?
There is no last upgrade for Marex Group
When was the last downgrade for Marex Group (MRX)?
There is no last downgrade for Marex Group.
When is the next analyst rating going to be posted or updated for Marex Group (MRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marex Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marex Group was filed on May 16, 2025 so you should expect the next rating to be made available sometime around May 16, 2026.
Is the Analyst Rating Marex Group (MRX) correct?
While ratings are subjective and will change, the latest Marex Group (MRX) rating was a maintained with a price target of $42.00 to $48.00. The current price Marex Group (MRX) is trading at is $44.17, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
